Common treatment‐related AEs included induration at the injection site (n = 5, 56%), injection site pain (n = 2, 22%), itchy skin (n = 3, 33%), anemia (n = 2, 22%), increased TSH (n = 2, 22%) and increased ALT (n = 2, 22%). The gene discussed is GPT; the disease is anemia (phenotype).